Anshika Gubrele and Subodh Asthana, both students at Bharati Vidyapeeth (Deemed to be University) New Law College, Pune and Hidayatullah National Law University, Raipur, in India, respectively, discuss the proposed patent waiver for manufacturing COVID-19 vaccines and its legal implications...
While the entire world is in the grips of the ongoing COVID-19 pandemic, 62 co-sponsor countries including India, South Africa, and Indonesia have recently given a revised draft proposal for waiving the Intellectual Property (“IP”) rights of COVID vaccines to the TRIPS Council of the World Trade Organisation (“WTO”), seeking a patent waiver for manufacturing various COVID-19 medical props including vaccines.